NVIVQ — InVivo Therapeutics Holdings Share News
0.000.00%
Last trade - 00:00Brief: InVivo Therapeutics Announces $9 Million Registered Direct And Private Placement Offerings, Priced At-The-Market Under Nasdaq Rules
U.S. STOCKS ON THE MOVE-Global Blood, Alibaba.com, Albemarle
Brief: Invivo Therapeutics Announces Publication Of 12- And 24-Month Data For Inspire 1.0 Study
Brief: Invivo Therapeutics Announces Completion Of Enrollment For The Inspire 2.0 Acute Spinal Cord Injury Study
U.S. STOCKS ON THE MOVE-Twitter, Didi Global, Natus, Casa Systems
U.S. STOCKS ON THE MOVE-Twitter, Cryoport, Biogen, iSun, Synchrony Financial, Natus Medical
InVivo Therapeutics falls after announcing reverse stock split
Brief: Invivo Therapeutics Announces Reverse Stock Split
Brief: Invivo Says 75% Target Enrollment Achieved For Inspire 2.0 Spinal Cord Injury Study
InVivo Therapeutics soars as its preclinical module gets FDA's nod
Brief: InVivo Therapeutics Announces FDA Acceptance Of Preclinical Module In Support Of Co’S Complete HDE Submission
Brief: Invivo Therapeutics Says Received Notice From Nasdaq Of Failure To Satisfy A Continued Listing Rule
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
InVivo expects to sign Soufflet takeover deal within two weeks (updated)
Brief: InVivo Therapeutics Announces Publication In Peer-Reviewed Journal Of Neurosurgery: Spine
Brief: Invivo Therapeutics Holdings Says Received Letter From Nasdaq That Co Has Regained Compliance With Minimum Bid Price Requirement
Brief: Invivo Therapeutics Receives Nasdaq Letter Notifying Bid Price For Common Stock Had Closed Below Minimum Listing Requirement
Brief: InVivo Announces Pricing Of $15 Million Public Offering